SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027389
Filing Date
2018-11-06
Accepted
2018-11-06 16:03:06
Documents
73
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-10q_20180930.htm 10-Q 2079597
2 EX-10.4 prtk-ex104_139.htm EX-10.4 41958
3 EX-31.1 prtk-ex311_9.htm EX-31.1 18172
4 EX-31.2 prtk-ex312_11.htm EX-31.2 18338
5 EX-32.1 prtk-ex321_8.htm EX-32.1 6534
6 EX-32.2 prtk-ex322_6.htm EX-32.2 6434
  Complete submission text file 0001564590-18-027389.txt   7803105

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT prtk-20180930.xml EX-101.INS 1536807
8 XBRL TAXONOMY EXTENSION SCHEMA prtk-20180930.xsd EX-101.SCH 66925
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtk-20180930_cal.xml EX-101.CAL 52040
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtk-20180930_def.xml EX-101.DEF 221971
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20180930_lab.xml EX-101.LAB 480704
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20180930_pre.xml EX-101.PRE 366168
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 181162936
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1